Skip to main content
Premium Trial:

Request an Annual Quote

GenMark, Advanced Liquid Logic to Collaborate on IVD Platform

NEW YORK (GenomeWeb News) – GenMark Diagnostics and Advanced Liquid Logic today announced a Heads of Agreement defining the terms of a partnership to develop an all-electronic fully integrated in vitro diagnostic platform.

The platform will combine GenMark's proprietary electrochemical detection and ALL's proprietary electrowetting technology.

GenMark President and CEO Hany Massarany said in a statement that the new technology will deliver a digital sample-to-answer platform. The initial focus will be on multiplex molecular testing, followed by efforts in other diagnostic areas including protein detection and point-of-care testing.

Financial and other terms were not disclosed.

Durham, NC-based Advanced Liquid Logic develops microfluidics products for newborn screening and genomic sample preparation.

The deal follows GenMark's announcement last week that it had licensed microfluidics IP from PerkinElmer for multiplexed molecular testing applications.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.